Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.
2.

Insulin-like growth factor II-messenger RNA-binding protein-3 and lung cancer.

Findeis-Hosey JJ, Xu H.

Biotech Histochem. 2012 Jan;87(1):24-9. doi: 10.3109/10520295.2011.591831. Epub 2011 Aug 15. Review.

PMID:
21838610
3.

Molecular and cellular biology of neuroendocrine lung tumors: evidence for separate biological entities.

Swarts DR, Ramaekers FC, Speel EJ.

Biochim Biophys Acta. 2012 Dec;1826(2):255-71. doi: 10.1016/j.bbcan.2012.05.001. Epub 2012 May 10. Review.

PMID:
22579738
4.

The use of insulin like-growth factor II messenger RNA binding protein-3 in diagnostic pathology.

Findeis-Hosey JJ, Xu H.

Hum Pathol. 2011 Mar;42(3):303-14. doi: 10.1016/j.humpath.2010.06.003. Epub 2010 Oct 20. Review.

PMID:
20970161
5.

[Neuroendocrine tumors of the lung].

Takei H, Asamura H.

Nihon Rinsho. 2004 May;62(5):877-82. Review. Japanese.

PMID:
15148812
6.

Pathology and diagnosis of neuroendocrine tumors: lung neuroendocrine.

Travis WD.

Thorac Surg Clin. 2014 Aug;24(3):257-66. doi: 10.1016/j.thorsurg.2014.04.001. Review.

PMID:
25065926
8.

Advances in neuroendocrine lung tumors.

Travis WD.

Ann Oncol. 2010 Oct;21 Suppl 7:vii65-71. doi: 10.1093/annonc/mdq380. Review.

PMID:
20943645
9.

Neuroendocrine tumors of the lung: an update.

Rekhtman N.

Arch Pathol Lab Med. 2010 Nov;134(11):1628-38. doi: 10.1043/2009-0583-RAR.1. Review.

PMID:
21043816
10.

Moderately differentiated neuroendocrine carcinoma (atypical carcinoid) of the parotid gland: report of three cases with contemporary review of salivary neuroendocrine carcinomas.

Said-Al-Naief N, Sciandra K, Gnepp DR.

Head Neck Pathol. 2013 Sep;7(3):295-303. doi: 10.1007/s12105-013-0431-6. Epub 2013 Mar 2. Review.

11.

[Neuroendocrine tumors of the lungs. From small cell lung carcinoma to diffuse idiopathic pulmonary neuroendocrine cell hyperplasia].

Schnabel PA, Junker K.

Pathologe. 2014 Nov;35(6):557-64. doi: 10.1007/s00292-014-1917-z. Review. German.

PMID:
25366372
12.

Neuroendocrine cells and associated malignancies of the oral mucosa: a review.

Mahomed F.

J Oral Pathol Med. 2010 Feb;39(2):121-7. doi: 10.1111/j.1600-0714.2009.00834.x. Epub 2009 Dec 8. Review.

PMID:
20002872
13.

Neuroendocrine tumors of the lung: clinical, pathologic, and imaging findings.

Chong S, Lee KS, Chung MJ, Han J, Kwon OJ, Kim TS.

Radiographics. 2006 Jan-Feb;26(1):41-57; discussion 57-8. Review.

PMID:
16418242
14.

Systemic therapy for pulmonary carcinoids.

Marquez-Medina D, Popat S.

Lung Cancer. 2015 Nov;90(2):139-47. doi: 10.1016/j.lungcan.2015.08.018. Epub 2015 Sep 12. Review.

PMID:
26371699
15.

Peptide receptors in neuroendocrine tumors of the lung as potential tools for radionuclide diagnosis and therapy.

Pelosi G, Volante M, Papotti M, Sonzogni A, Masullo M, Viale G.

Q J Nucl Med Mol Imaging. 2006 Dec;50(4):272-87. Review.

16.

Therapeutic biomarkers in lung neuroendocrine neoplasia.

Righi L, Volante M, Rapa I, Vatrano S, Pelosi G, Papotti M.

Endocr Pathol. 2014 Dec;25(4):371-7. doi: 10.1007/s12022-014-9335-6. Review.

17.

Neuroendocrine tumors of the gynecologic tract: select topics.

Rouzbahman M, Clarke B.

Semin Diagn Pathol. 2013 Aug;30(3):224-33. doi: 10.1053/j.semdp.2013.06.007. Review.

PMID:
24144291
18.

Low-Grade Neuroendocrine Carcinoma of the Skin (Primary Cutaneous Carcinoid Tumor) as a Distinctive Entity of Cutaneous Neuroendocrine Tumors: A Clinicopathologic Study of 3 Cases With Literature Review.

Goto K, Anan T, Nakatsuka T, Kaku Y, Sakurai T, Fukumoto T, Kimura T, Shibata A.

Am J Dermatopathol. 2017 Apr;39(4):250-258. doi: 10.1097/DAD.0000000000000657. Review.

PMID:
28169866
19.

Low Grade Neuroendocrine Tumors of the Lung.

Melosky B.

Front Oncol. 2017 Jun 13;7:119. doi: 10.3389/fonc.2017.00119. eCollection 2017. Review.

Supplemental Content

Support Center